NormaTec Via

• Covered by health insurers including Medicare, most HMOs, and the VA
• FDA cleared, numerous safety features that meet demanding UL 2601 and CE safety standards
• Built-in protection against clinically inappropriate pressures and reverse gradients so that adverse settings cannot be inadvertently programmed
• Small, light design (3.2lb)
• Easy on-and-off attachments and one simple connection
• Can be used on the arms, legs, or hips (even over amputations)
• 5 overlapping zones
• Calibration phase for a perfect fit every treatment
• 30-110mmHg compression range
• Whisper quiet technology
• Precise digital control and accuracy

NormaTec Via is FDA cleared for treatment of: lymphedema (secondary to cancer and also following trauma, inflammation, surgery and/or radiation treatment); congenital lymphedema (Millroy’s disease, lymphedema praecox, and lymphedema tarda); venous insufficiency; venous stasis ulceration; chronic non-healing wounds; other edematous conditions; and for prevention of DVT.

The NormaTec Via Series is contraindicated for patients with:
Acute deep vein thrombosis
Severe atherosclerosis or other ischemic vascular diseases
Suspected or known acute deep vein thrombosis
Severe congestive cardiac failure
Existing pulmonary edema
Existing pulmonary embolism
Extreme deformity of the limbs
Any local skin or tissue condition which the garments would interfere with such as gangrene, untreated or infected wounds, recent skin graft, and dermatitis
Known presence of malignancy in the legs
Limb infections, including cellulitis, that have not received antibiotic coverage
Presence of lymphangiosarcoma